On the Future of Everything radio show, Stanford bioengineer Jennifer Cochran discusses her development of "tumor-targeting missiles" that deliver chemotherapy as "cargo" to more effectively kill cancer.
Clinicians now have up to 24 hours to treat a stroke, thanks in part to research and tools developed at Stanford Medicine.
A new mini-experiment from Stanford's WELL program challenges individuals to take five minutes out of their day to meditate, with the goal of improving well-being.
This Stars of Stanford Medicine Q&A features anesthesiologist and researcher Vivianne Tawfik, who examines the roots of chronic pain.
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
A new technique gives doctors an early view of which pediatric leukemia patients will relapse, and may point the way toward better cancer drugs.
Scientists have used genome editing to pinpoint genes that reveal information about ALS and may even protect against the degeneration of neurons.
In this video, Stanford psychologist David Spiegel discusses how hypnosis reduces pain and could help curb the opioid crisis.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
Researchers have found a way to turn off a key driver of inflammation in celiac disease, an autoimmune disease that affects millions of Americans.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
As part of the "Breaking down diabetes" series, physician Randall Stafford provides a straightforward guide to medications that can treat Type 2 diabetes.
Tuberculosis is a major public health problem worldwide, yet most people lack access to quick, reliable testing. Now, chemists have found a solution.
Years into the opioid epidemic, Stanford psychiatrist and addiction researcher Anna Lembke cites signs of slow improvement and comments on benzodiazepines.
To broaden access to proven strategies for treating eating disorders, Stanford specialists have published a book to help those struggling with the disease.